Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_assertion type Assertion NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_head.
- NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_assertion description "[Within 17q, the genes topoisomerase II-alpha (TOP2A), ets variant gene 4 (E1A enhancer binding protein, E1AF) (ETV4) and baculoviral IAP repeat-containing 5 (survivin) (BIRC5) showed increased expression in all samples compared to two benign tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_provenance.
- NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_assertion evidence source_evidence_literature NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_provenance.
- NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_assertion SIO_000772 18522746 NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_provenance.
- NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_assertion wasDerivedFrom befree-20140225 NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_provenance.
- NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_assertion wasGeneratedBy ECO_0000203 NP199368.RAH-ZfGkm6KIoxdGdj2weLnwPmScbrEea_RhpzzVDNZFs130_provenance.